| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |